These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3681416)

  • 1. Subcellular localisation of gadolinium in the rat brain.
    Allard M; Kien P; Caille JM; Bonnemain B; Doucet D; Simonnet G
    J Neuroradiol; 1987; 14(2):159-62. PubMed ID: 3681416
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain distribution of MRI contrast media in rats after intracisternal injection.
    Allard M; Kien P; Caille JM; Bonnemain B; Simonnet G
    J Neuroradiol; 1987; 14(4):383-7. PubMed ID: 3131496
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal handling and physiologic effects of the paramagnetic contrast medium, gadolinium-DOTA.
    Katzberg RW; Sahler LG; Duda SW; Morris TW; McKenna BA; Pabico RC; Niedrach WL; Tonetti FW
    Invest Radiol; 1991 Nov; 26 Suppl 1():S129-30; discussion S137-8. PubMed ID: 1808108
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution and chemical forms of gadolinium in the brain: a review.
    Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
    Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.
    Tweedle MF
    Invest Radiol; 1992 Aug; 27 Suppl 1():S2-6. PubMed ID: 1506149
    [No Abstract]   [Full Text] [Related]  

  • 6. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P760: a new gadolinium complex characterized by a low rate of interstitial diffusion.
    Port M; Corot C; Raynal I; Dencausse A; Schaefer M; Rousseaux O; Simonot C; Devoldere L; Lin J; Foulon M; Bourrinet P; Bonnemain B; Meyer D
    Acad Radiol; 2002 May; 9 Suppl 1():S17-9. PubMed ID: 12019859
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.
    Bussi S; Coppo A; Botteron C; Fraimbault V; Fanizzi A; De Laurentiis E; Colombo Serra S; Kirchin MA; Tedoldi F; Maisano F
    J Magn Reson Imaging; 2018 Mar; 47(3):746-752. PubMed ID: 28730643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of gadolinium chelates and their biological consequences: new data and some comments.
    Port M; Idee JM; Medina C; Dencausse A; Corot C
    Br J Radiol; 2008 Mar; 81(963):258-9. PubMed ID: 18270297
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
    Fretellier N; Salhi M; Schroeder J; Siegmund H; Chevalier T; Bruneval P; Jestin-Mayer G; Delaloge F; Factor C; Mayer JF; Fabicki JM; Robic C; Bonnemain B; Idée JM; Corot C
    Eur J Pharm Sci; 2015 May; 72():46-56. PubMed ID: 25736527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of macrocyclic gadolinium chelates as hepatospecific MRI agents.
    Marinelli ER; Neubeck R; Song B; Wagler T; Ranganathan RS; Sukumaran K; Wedeking P; Nunn A; Runge V; Tweedle M
    Acad Radiol; 2002 May; 9 Suppl 1():S251-4. PubMed ID: 12019882
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.
    Murata N; Gonzalez-Cuyar LF; Murata K; Fligner C; Dills R; Hippe D; Maravilla KR
    Invest Radiol; 2016 Jul; 51(7):447-53. PubMed ID: 26863577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual or retained gadolinium: practical implications for radiologists and our patients.
    Kanal E; Tweedle MF
    Radiology; 2015 Jun; 275(3):630-4. PubMed ID: 25942418
    [No Abstract]   [Full Text] [Related]  

  • 14. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium.
    Jacquier A; Wendland M; Do L; Robert P; Corot C; Higgins CB; Saeed M
    Contrast Media Mol Imaging; 2008; 3(3):112-9. PubMed ID: 18548477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging folate binding protein expression with MRI.
    Wiener EC; Konda SD; Wang S; Brechbiel M
    Acad Radiol; 2002 Aug; 9 Suppl 2():S316-9. PubMed ID: 12188260
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
    McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
    Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a high-generation dendrimer-Gd-DOTA.
    Bryant LH; Jordan EK; Bulte JW; Herynek V; Frank JA
    Acad Radiol; 2002 May; 9 Suppl 1():S29-33. PubMed ID: 12019888
    [No Abstract]   [Full Text] [Related]  

  • 19. Considerations involving paramagnetic coordination compounds as useful NMR contrast agents.
    Tweedle MF; Gaughan GT; Hagan J; Wedeking PW; Sibley P; Wilson LJ; Lee DW
    Int J Rad Appl Instrum B; 1988; 15(1):31-6. PubMed ID: 3350694
    [No Abstract]   [Full Text] [Related]  

  • 20. Gadolinium Chelate Safety in Pregnancy: Barely Detectable Gadolinium Levels in the Juvenile Nonhuman Primate after in Utero Exposure.
    Prola-Netto J; Woods M; Roberts VHJ; Sullivan EL; Miller CA; Frias AE; Oh KY
    Radiology; 2018 Jan; 286(1):122-128. PubMed ID: 28873045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.